219 related articles for article (PubMed ID: 22840683)
1. Twelve-month results of the EverFlex stent in the superficial femoral artery.
Diehl SJ; Gerblich F; Jochum S; Huck K; Keese M; Schoenberg SO; Sadick M
J Vasc Interv Radiol; 2012 Oct; 23(10):1317-22. PubMed ID: 22840683
[TBL] [Abstract][Full Text] [Related]
2. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of the EPIC™ nitinol vascular stent system for the treatment of lesions located in the superficial femoral artery: prospective and multicentric trial.
Nasser F; Kambara A; Abath C; Cavalcanti D; Barros I; Pires N; Rivera M; Neser A; Ingrund J; Burihan M; Silveira P; Galego G; Bortoluzzi C; Franklin R; Bosiers M; Deloose K; Razuk A; Caffaro R; Karakhanian WK; Park J; Lopes C; Pinto D; Bez L; Lopes R; Mourão A; Kleinsorge G
J Cardiovasc Surg (Torino); 2017 Jun; 58(3):409-415. PubMed ID: 25731858
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
[TBL] [Abstract][Full Text] [Related]
5. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
[TBL] [Abstract][Full Text] [Related]
6. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial.
Laird JR; Jain A; Zeller T; Feldman R; Scheinert D; Popma JJ; Armstrong EJ; Jaff MR;
J Endovasc Ther; 2014 Apr; 21(2):202-12. PubMed ID: 24754279
[TBL] [Abstract][Full Text] [Related]
7. Stent fractures after superficial femoral artery stenting: risk factors and impact on patency.
Lin Y; Tang X; Fu W; Kovach R; George JC; Guo D
J Endovasc Ther; 2015 Jun; 22(3):319-26. PubMed ID: 25862365
[TBL] [Abstract][Full Text] [Related]
8. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
[TBL] [Abstract][Full Text] [Related]
9. First clinical experience with the Innova versus the Protege EverFlex self-expanding bare metal stents in superficial femoral artery occlusions.
Gabrielli R; Rosati MS; Chiappa R; Millarelli M; Marcuccio L; Siani A; Caselli G
Thorac Cardiovasc Surg; 2015 Mar; 63(2):158-63. PubMed ID: 25602844
[TBL] [Abstract][Full Text] [Related]
10. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
[TBL] [Abstract][Full Text] [Related]
11. SUPERA interwoven nitinol Stent Outcomes in Above-Knee IntErventions (SAKE) study.
George JC; Rosen ES; Nachtigall J; VanHise A; Kovach R
J Vasc Interv Radiol; 2014 Jun; 25(6):954-61. PubMed ID: 24768325
[TBL] [Abstract][Full Text] [Related]
12. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
[TBL] [Abstract][Full Text] [Related]
13. Endovascular treatment for symptomatic stent failures in long-segment chronic total occlusion of femoropopliteal arteries.
Yang X; Lu X; Li W; Huang Y; Huang X; Lu M; Jiang M
J Vasc Surg; 2014 Aug; 60(2):362-8. PubMed ID: 24680242
[TBL] [Abstract][Full Text] [Related]
14. Twelve-month experience with the GORE® TIGRIS® Vascular Stent in the superficial femoral and popliteal arteries.
Piorkowski M; Freitas B; Steiner S; Botsios S; Bausback Y; Scheinert D; Schmidt A
J Cardiovasc Surg (Torino); 2015 Feb; 56(1):89-95. PubMed ID: 25410147
[TBL] [Abstract][Full Text] [Related]
15. One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study).
Ohki T; Angle JF; Yokoi H; Jaff MR; Popma J; Piegari G; Kanaoka Y;
J Vasc Surg; 2016 Feb; 63(2):370-6.e1. PubMed ID: 26483003
[TBL] [Abstract][Full Text] [Related]
16. Duplex criteria for in-stent restenosis in the superficial femoral artery.
Kawarada O; Higashimori A; Noguchi M; Waratani N; Yoshida M; Fujihara M; Yokoi Y; Honda Y; Fitzgerald PJ
Catheter Cardiovasc Interv; 2013 Mar; 81(4):E199-205. PubMed ID: 22639187
[TBL] [Abstract][Full Text] [Related]
17. Bioabsorbable stent implantation vs. common femoral artery endarterectomy: early results of a randomized trial.
Linni K; Ugurluoglu A; Hitzl W; Aspalter M; Hölzenbein T
J Endovasc Ther; 2014 Aug; 21(4):493-502. PubMed ID: 25101576
[TBL] [Abstract][Full Text] [Related]
18. One-year follow-up after implantation of the EverFlex nitinol stent in long lesions of the superficial femoral artery.
Ruef J
Angiology; 2009; 60(1):31-5. PubMed ID: 18508851
[TBL] [Abstract][Full Text] [Related]
19. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
[TBL] [Abstract][Full Text] [Related]
20. Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions.
Bosiers M; Deloose K; Callaert J; Moreels N; Keirse K; Verbist J; Peeters P
J Vasc Surg; 2011 Oct; 54(4):1042-50. PubMed ID: 21636239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
